Stimulation of the Retinoid X Receptor Facilitates Beta-Amyloid Clearance Across the Blood–Brain Barrier (original) (raw)
Bachmeier C, Mullan M, Paris D (2010) Characterization and use of human brain microvascular endothelial cells to examine beta-amyloid exchange in the blood–brain barrier. Cytotechnology 62:519–529 ArticlePubMedCAS Google Scholar
Bachmeier C, Paris D, Beaulieu-Abdelahad D, Mouzon B, Mullan M, Crawford F (2012) A multifaceted role for apoe in the clearance of beta-amyloid across the blood–brain barrier. Neurodegener Dis. doi:10.1159/000337231
Bachmeier CJ, Beaulieu-Abdelahad D, Mullan MJ, Paris D (2011) Epitope-dependent effects of beta-amyloid antibodies on beta-amyloid clearance in an in vitro model of the blood–brain barrier. Microcirculation 18:373–379 ArticlePubMedCAS Google Scholar
Bu G (2009) Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10:333–344 ArticlePubMedCAS Google Scholar
Burgess JW, Marcel YL (2001) Dynamic and stable pools of apoE differ functionally at the hepg2 cell surface. J Lipid Res 42:1413–1420 PubMedCAS Google Scholar
Camacho IE, Serneels L, Spittaels K, Merchiers P, Dominguez D, De Strooper B (2004) Peroxisome-proliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide. J Neurosci 24:10908–10917 ArticlePubMedCAS Google Scholar
Castellano JM, Kim J, Stewart FR et al (2011) Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med 3:89ra57 Google Scholar
Chan GN, Hoque MT, Cummins CL, Bendayan R (2011) Regulation of p-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells. J Neurochem 118:163–175 ArticlePubMedCAS Google Scholar
Cirrito JR, Deane R, Fagan AM et al (2005) P-glycoprotein deficiency at the blood–brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest 115:3285–3290 ArticlePubMedCAS Google Scholar
Cramer PE, Cirrito JR, Wesson DW et al (2012) Apoe-directed therapeutics rapidly clear beta-amyloid and reverse deficits in ad mouse models. Science 335:1503–1506 ArticlePubMedCAS Google Scholar
Dawson MI, Xia Z (2012) The retinoid x receptors and their ligands. Biochim Biophys Acta 1821:21–56 ArticlePubMedCAS Google Scholar
Deane R, Sagare A, Hamm K et al (2008) Apoe isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 118:4002–4013 ArticlePubMedCAS Google Scholar
Do TM, Noel-Hudson MS, Ribes S et al (2012) Abcg2- and abcg4-mediated efflux of amyloid-beta peptide 1-40 at the mouse blood–brain barrier. J Alzheimers Dis 30:155–166 PubMedCAS Google Scholar
Fitz NF, Cronican A, Pham T et al (2010) Liver x receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in app 23 mice. J Neurosci 30:6862–6872 ArticlePubMedCAS Google Scholar
Gauthier A, Vassiliou G, Benoist F, McPherson R (2003) Adipocyte low density lipoprotein receptor-related protein gene expression and function is regulated by peroxisome proliferator-activated receptor gamma. J Biol Chem 278:11945–11953 ArticlePubMedCAS Google Scholar
Hessel S, Lampen A (2010) All-trans retinoic acid enhances the transport of phase ii metabolites of benzo[a]pyrene by inducing the breast cancer resistance protein expression in caco-2 cells. Toxicol Lett 197:151–155 ArticlePubMedCAS Google Scholar
Jiang Q, Lee CY, Mandrekar S et al (2008) Apoe promotes the proteolytic degradation of abeta. Neuron 58:681–693 ArticlePubMedCAS Google Scholar
Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer’s disease. Neuron 63:287–303 ArticlePubMedCAS Google Scholar
Kockx M, Guo DL, Huby T et al (2007) Secretion of apolipoprotein e from macrophages occurs via a protein kinase A and calcium-dependent pathway along the microtubule network. Circ Res 101:607–616 ArticlePubMedCAS Google Scholar
Kockx M, Jessup W, Kritharides L (2008) Regulation of endogenous apolipoprotein E secretion by macrophages. Arterioscler Thromb Vasc Biol 28:1060–1067 ArticlePubMedCAS Google Scholar
Krohn M, Lange C, Hofrichter J et al (2011) Cerebral amyloid-beta proteostasis is regulated by the membrane transport protein abcc1 in mice. J Clin Invest 121:3924–3931 ArticlePubMedCAS Google Scholar
Kuhnke D, Jedlitschky G, Grube M et al (2007) Mdr1-p-glycoprotein (abcb1) mediates transport of Alzheimer’s amyloid-beta peptides–implications for the mechanisms of abeta clearance at the blood–brain barrier. Brain Pathol 17:347–353 ArticlePubMedCAS Google Scholar
LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer’s disease. Nat Rev Neurosci 8:499–509 ArticlePubMedCAS Google Scholar
Lefebvre P, Benomar Y, Staels B (2010) Retinoid x receptors: common heterodimerization partners with distinct functions. Trends Endocrinol Metab 21:676–683 ArticlePubMedCAS Google Scholar
Liang Y, Lin S, Beyer TP et al (2004) A liver x receptor and retinoid x receptor heterodimer mediates apolipoprotein e expression, secretion and cholesterol homeostasis in astrocytes. J Neurochem 88:623–634 ArticlePubMedCAS Google Scholar
Lucas M, Mazzone T (1996) Cell surface proteoglycans modulate net synthesis and secretion of macrophage apolipoprotein E. J Biol Chem 271:13454–13460 ArticlePubMedCAS Google Scholar
Mawuenyega KG, Sigurdson W, Ovod V et al (2010) Decreased clearance of CNS beta-amyloid in Alzheimer’s disease. Science 330:1774 ArticlePubMedCAS Google Scholar
McLean CA, Cherny RA, Fraser FW et al (1999) Soluble pool of abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease. Ann Neurol 46:860–866 ArticlePubMedCAS Google Scholar
Mehta PD (2007) Amyloid beta protein as a marker or risk factor of Alzheimer’s disease. Curr Alzheimer Res 4:359–363 ArticlePubMedCAS Google Scholar
Nordberg A (2008) Amyloid imaging in Alzheimer’s disease. Neuropsychologia 46:1636–1641 ArticlePubMed Google Scholar
Paris D, Bachmeier C, Patel N et al (2011) Selective antihypertensive dihydropyridines lower abeta accumulation by targeting both the production and the clearance of abeta across the blood–brain barrier. Mol Med 17:149–162 ArticlePubMedCAS Google Scholar
Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N (1992) Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 89:4471–4475 ArticlePubMedCAS Google Scholar
Podlisny MB, Ostaszewski BL, Squazzo SL et al (1995) Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem 270:9564–9570 ArticlePubMedCAS Google Scholar
Podlisny MB, Walsh DM, Amarante P et al (1998) Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red. Biochemistry 37:3602–3611 ArticlePubMedCAS Google Scholar
Shibata M, Yamada S, Kumar SR et al (2000) Clearance of Alzheimer’s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood–brain barrier. J Clin Invest 106:1489–1499 ArticlePubMedCAS Google Scholar
Suon S, Zhao J, Villarreal SA et al (2010) Systemic treatment with liver x receptor agonists raises apolipoprotein E, cholesterol, and amyloid-beta peptides in the cerebral spinal fluid of rats. Mol Neurodegener 5:44 ArticlePubMed Google Scholar
Tai LM, Loughlin AJ, Male DK, Romero IA (2009) P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta. J Cereb Blood Flow Metab 29:1079–1083 ArticlePubMedCAS Google Scholar
Tao H, Aakula S, Abumrad NN, Hajri T (2010) Peroxisome proliferator-activated receptor-gamma regulates the expression and function of very-low-density lipoprotein receptor. Am J Physiol Endocrinol Metab 298:E68–E79 ArticlePubMedCAS Google Scholar
Tsukuda K, Mogi M, Iwanami J et al (2009) Cognitive deficit in amyloid-beta-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-gamma activation. Hypertension 54:782–787 ArticlePubMedCAS Google Scholar
Vogelgesang S, Cascorbi I, Schroeder E et al (2002) Deposition of Alzheimer’s beta-amyloid is inversely correlated with p-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics 12:535–541 ArticlePubMedCAS Google Scholar
Weller RO, Boche D, Nicoll JA (2009) Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy. Acta Neuropathol 118:87–102 ArticlePubMedCAS Google Scholar
Wells JM, Amaratunga A, McKenna DC, Abraham CR, Fine RE (1995) Amyloid β-protein precursor and apolipoprotein e production in cultured cerebral endothelial cells isolated from brains of patients with neurodegenerative disorders at autopsy. Amyloid 2:229–233 ArticleCAS Google Scholar
Yue L, Mazzone T (2009) Peroxisome proliferator-activated receptor gamma stimulation of adipocyte apoe gene transcription mediated by the liver receptor x pathway. J Biol Chem 284:10453–10461 ArticlePubMedCAS Google Scholar
Zelcer N, Khanlou N, Clare R et al (2007) Attenuation of neuroinflammation and Alzheimer’s disease pathology by liver x receptors. Proc Natl Acad Sci USA 104:10601–10606 ArticlePubMedCAS Google Scholar
Zhong N, Weisgraber KH (2009) Understanding the basis for the association of apoe4 with Alzheimer’s disease: opening the door for therapeutic approaches. Curr Alzheimer Res 6:415–418 ArticlePubMedCAS Google Scholar